Meniere's disease

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
3 Unique sponsors
7 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
N Neurology/Psychiatry (ATC N) 1
A Gastroenterology (ATC A) 1
B Haematology (ATC B) 1
H Endocrinology (ATC H) 1
J Anti-infectives (ATC J) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Corticosteroid 2 substances
Aminoglycoside 1 substance
Supportive / diluent 1 substance
Phase III: 2 Other: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

2 trials
  • Intas Pharmaceuticals Limited Commercial
    BETAHISTINE DIHYDROCHLORIDE
    2024-518347-38-00 1 country 2022 n=328
    Recruiting
  • Leiden University Medical Center Academic
    DEXAMETHASONE; GENTAMICIN; METHYLPREDNISOLONE; METOCLOPRAMIDE; SODIUM CHLORIDE; TRIAMCINOLONE ACETONIDE
    2023-503340-13-00 1 country 2023 n=148
    Recruiting

Other

1 trial
  • Esperante Development B.V. Commercial
    IMP not specified
    2025-522971-27-00 1 country 2025 n=24
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Esperante Development B.V. Commercial 1 Other 0
Intas Pharmaceuticals Limited Commercial 1 Phase III 1
Leiden University Medical Center Academic 1 Phase III 1
New trials by year
2022
1
2023
1
2025
1
← All indication landscapes